RIFAMPIN (RIFAMPIN) — FDA Approval ANDA065421 (MYLAN LABS LTD)
RIFAMPIN (RIFAMPIN) — FDA Approval ANDA065421 (MYLAN LABS LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: RIFAMPIN; Active ingredients: RIFAMPIN; Application number: ANDA065421.
| Brand name | RIFAMPIN |
|---|---|
| Active ingredients | RIFAMPIN |
| Application number | ANDA065421 |
| Sponsor | MYLAN LABS LTD |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20080522 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →